Skip to main content

Value ETFs Climb as U.S. Markets Pare Early Losses

Value stocks and related exchange traded funds rallied on Friday to kick off the new quarter, paring early morning losses as investors turned more risk-on. Supporting the improved sentiment, Merck & Co Inc revealed positive trial data for its experimental oral drug for COVID-19, molnupiravir....
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.